New strategy fights bacterial antibiotic resistance

A new strategy to combat antibiotic resistance has emerged from a study led by researchers at Baylor College of Medicine. Published in the journal Molecular Cell, the report reveals for the first time how bacteria evolve mutations that confer antibiotic resistance and that this process can be inhibited with FDA-approved drug edaravone.

Article: Baylor College of Medicine

Smart Innovations  

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!